Xaira Therapeutics
AI-driven drug discovery and development
CORE INFO
Xaira Therapeutics is a biotechnology company that uses artificial intelligence to enhance drug discovery and development, focusing on creating targeted therapeutics for specific patient populations.
- Xaira Therapeutics recently raised $500 million in a Series A funding round, co-led by ARCH Venture Partners and Foresite Capital.businesswire.com
- TechCrunch reported on Xaira's launch, highlighting its substantial $1 billion initial funding and readiness to start developing drugs using AI.techcrunch.com
WHY WE WOULD WORK AT XAIRA THERAPEUTICS
Pioneering AI Innovation
Join a team that's at the forefront of AI-driven drug discovery, leveraging cutting-edge technology to develop life-changing medicines.
Transform Lives
Contribute to a mission that aims to revolutionize healthcare by creating therapeutics that significantly improve patient outcomes.
Collaborative Culture
Work alongside a multidisciplinary team of experts in drug discovery, protein design, and machine learning, fostering innovation through collaboration.
Strong Funding Backing
Benefit from substantial financial support, with over $1 billion raised, ensuring resources for ambitious projects and employee growth.
Rapid Growth Opportunities
Be part of a rapidly expanding company, with a team size that has grown by over 1000% in just one year, offering ample career advancement.
Cutting-Edge Technology
Utilize advanced AI models and multidimensional data sets to enhance disease understanding and therapeutic development, transforming drug discovery into a precise engineering discipline.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
KEY METRICS
✦ KEY METRICCOMPETITIVE ADVANTAGE
MARKET POSITION
SERVICES
PRODUCT AND TECH
AI-Driven Drug Discovery
Xaira Therapeutics utilizes advanced AI models to predict optimal biological targets and design therapeutics, significantly enhancing the efficiency and accuracy of the drug discovery process.
Multidimensional Data Integration
The company generates and integrates comprehensive data sets that span molecular to human scales, improving disease understanding and therapeutic development through a holistic approach.
Differentiated Therapeutics Development
Focusing on multiple modalities, Xaira aims to create innovative therapeutics that address unmet medical needs, transforming drug discovery into a precise engineering discipline.
Collaborative Innovation
Xaira emphasizes collaboration among experts in drug discovery, protein design, machine learning, and data science, fostering a multidisciplinary approach to advance therapeutic development.
Predictive AI Models
The company specializes in developing predictive and agentic AI models that enhance biological modeling, enabling more effective drug design and patient population identification.